Pandemic influenza A/H1N1 2009: Challenge for intensive care medicine;Neue Influenza-A/H1N1-2009-Virus-Pandemie: Herausforderung für die Intensivmedizin

Anaesthesist

Volumn 59, Issue 1, 2010, Pages 11-22

  Burkle M A ^a   Frey, L ^a   Zwiler, B ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; H1N1; Influenza; Intensive care unit

Indexed keywords

ANTIVIRUS AGENT;

ANAMNESIS; ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; CASE REPORT; CRITICALLY ILL PATIENT; DECISION MAKING; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; EXTRACORPOREAL OXYGENATION; HUMAN; HYGIENE; INCIDENCE; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LUNG DISEASE; OUTPATIENT; PANDEMIC; PATIENT CARE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS;

EXTRACORPOREAL MEMBRANE OXYGENATION; GERMANY; HOSPITALIZATION; HUMANS; HYGIENE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE; INTENSIVE CARE UNITS; PANDEMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS SHEDDING;

EID: 77950446550     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-009-1667-0     Document Type: Review

References (36)

1. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z et al (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358:261-273
2. Agarwal PP, Cinti S, Kazerooni EA (2009) Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR Am J Roentgenol 193:1488-1493
3. Birnkrant D, Cox E (2009) The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 361:2204-2207
4. Bishop JF, Murnane MP, Owen R (2009) Australias winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 361:2591-2594
5. Cohen D (2009) Complications: tracking down the data on oseltamivir. BMJ 339:b5387
6. Davies A, Jones D, Bailey M et al (2009) Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302:1888-1895
7. De Serres G, Rouleau I, Hamelin M et al (2009) Shedding of novel 2009 pandemic H1N1 (nH1N1) virus at one week post illness onset. In: 49th Conference on Antimicrobial Agents and Chemotherapy 2009. K1918a, San Francisco, CA, USA
8. Domnguez-Cherit G, Lapinsky SE, Macias AE et al (2009) Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302:1880-1887
9. Doshi P (2009) Neuraminidase inhibitors - the story behind the Cochrane review. BMJ 339:b5164
10. Faix DJ, Sherman SS, Waterman SH (2009) Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 361:728-729
11. Fraser C, Donnelly CA, Cauchemez S et al (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324:1557-1561
12. Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201
13. Greenberg ME, Lai MH, Hartel GF et al (2009) Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 361:2405-2413
14. Jefferson T, Jones M, Doshi P et al (2009) Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 339:b5106
15. Jefferson TO, Demicheli V, Di Pietrantonj C et al (2006) Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 3:CD001265
16. Kaiser L, Wat C, Mills T et al (2003) Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 163:1667-1672
17. Kaisers U, Zwissler B, Rossaint R (2010) Neue pandemische A(H1N1)-Influenza - Sind unsere intensivmedizinischen Ressourcen ausreichend? Anaesthesist, doi s00101-009-1668-z
18. Khazeni N, Hutton DW, Garber AM et al (2009) Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med 151:829-839
19. Kumar A, Zarychanski R, Pinto R et al (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302:1872-1879
20. Lye D, Chow A, Tan A et al (2009) Oseltamivir therapy and viral shedding in pandemic (H1N1) 2009. In: 49th Conference on Antimicrobial Agents and Chemotherapy 2009. V1269c, San Francisco, CA, USA
21. Mai LQ, Wertheim HF, Duong TN et al (2010) A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 362:86-87
22. Morens DM, Taubenberger JK (2009) Understanding influenza backward. JAMA 302:679-680
23. Morens DM, Taubenberger JK, Fauci AS (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361:225-229
24. Morens DM, Taubenberger JK, Fauci AS (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198:962-970
25. Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351-1363
26. Plennevaux E, Sheldon E, Blatter M et al (2010) Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 375: 41-48
27. Rello J, Rodrguez A, Ibaez P et al (2009) Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 13:R148
28. Schaberg T, Bauer T, Dalhoff K et al (2009) Management of a new influenza A/H1N1 virus pandemic within the hospital: statement of the German Society of Pneumology. Pneumologie 63:417-425
29. Smith JR, Ariano RE, Toovey S (2009) The use of antiviral agents for the management of severe influenza. Crit Care Med, doi 10.1097/CCM.0b013e3181c85229
30. Taylor WR, Thinh BN, Anh GT et al (2008) Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS ONE 3:e3410
31. Thorpe C, Darcy S (2009) A/H1N1 flu pandemic. Consider bronchoalveolar lavage. BMJ 339:b5094
32. Treanor JJ, Hayden FG, Vrooman PS et al (2000) Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 283:1016-1024
33. Uyeki T (2009) Diagnostic testing for 2009 pandemic influenza A (H1N1) virus infection in hospitalized patients. N Engl J Med 361:e114
34. Webb SA, Pettilä V, Seppelt I et al (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361:1925-1934
35. Winzer R, Kanig N, Schneitler S et al (2009) Early clinical experiences with the new influenza a (H1N1/09). Dtsch Arztebl 106:770-776
36. Yang Y, Sugimoto JD, Halloran ME et al (2009) The transmissibility and control of pandemic influenza A (H1N1) virus. Science 326:729-733